{"name":"Fred Hutchinson Cancer Center","slug":"fred-hutchinson-cancer-center","ticker":"","exchange":"","domain":"fredhutch.org","description":"The Fred Hutchinson Cancer Center, formerly known as the Fred Hutchinson Cancer Research Center and also known as Fred Hutch or The Hutch, is a cancer research institute established in 1975 in Seattle, Washington.","hq":"Seattle","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-12-01","label":"chemoprotection Phase 2 readout (Uncomplicated Falciparum Malaria)","drug":"chemoprotection","drugSlug":"chemoprotection","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":10,"colorKey":"oncology","drugs":[{"name":"Nicotine Lozenge","genericName":"Nicotine Lozenge","slug":"nicotine-lozenge","indication":"Other","status":"marketed"},{"name":"Recombinant Granulocyte Colony-Stimulating Factor","genericName":"Recombinant Granulocyte Colony-Stimulating Factor","slug":"recombinant-granulocyte-colony-stimulating-factor","indication":"Other","status":"marketed"},{"name":"TLR4 Agonist GLA-SE","genericName":"TLR4 Agonist GLA-SE","slug":"tlr4-agonist-gla-se","indication":"Other","status":"phase_1"},{"name":"Wistar Rabies Virus Strain PM-1503-3M Vaccine","genericName":"Wistar Rabies Virus Strain PM-1503-3M Vaccine","slug":"wistar-rabies-virus-strain-pm-1503-3m-vaccine","indication":"Other","status":"phase_1"},{"name":"Beta Carotene and Retinol","genericName":"Beta Carotene and Retinol","slug":"beta-carotene-and-retinol","indication":"Other","status":"marketed"},{"name":"Garlic oil","genericName":"Garlic oil","slug":"garlic-oil","indication":"Other","status":"marketed"},{"name":"Nicotine Gum","genericName":"Nicotine Gum","slug":"nicotine-gum","indication":"Other","status":"marketed"},{"name":"Nozin","genericName":"Nozin","slug":"nozin","indication":"Other","status":"discontinued"},{"name":"T-cell Receptor-engineered T-cells","genericName":"T-cell Receptor-engineered T-cells","slug":"t-cell-receptor-engineered-t-cells","indication":"Other","status":"phase_1"},{"name":"chemoprotection","genericName":"chemoprotection","slug":"chemoprotection","indication":"Other","status":"discontinued"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"JAK Inhibitor","genericName":"JAK Inhibitor","slug":"jak-inhibitor","indication":"Myeloproliferative neoplasms (e.g., polycythemia vera, essential thrombocythemia, primary myelofibrosis)","status":"marketed"},{"name":"Liposome-encapsulated Daunorubicin-Cytarabine","genericName":"Liposome-encapsulated Daunorubicin-Cytarabine","slug":"liposome-encapsulated-daunorubicin-cytarabine","indication":"Acute myeloid leukemia (AML) in elderly or unfit patients","status":"phase_3"},{"name":"endocrine-modulating drug therapy","genericName":"endocrine-modulating drug therapy","slug":"endocrine-modulating-drug-therapy","indication":"Hormone receptor-positive breast cancer","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Atripla or Stribild","genericName":"Atripla or Stribild","slug":"atripla-or-stribild","indication":"HIV-1 infection in treatment-naïve and treatment-experienced patients (Atripla)","status":"marketed"}]}],"pipeline":[{"name":"Nicotine Lozenge","genericName":"Nicotine Lozenge","slug":"nicotine-lozenge","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Recombinant Granulocyte Colony-Stimulating Factor","genericName":"Recombinant Granulocyte Colony-Stimulating Factor","slug":"recombinant-granulocyte-colony-stimulating-factor","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"TLR4 Agonist GLA-SE","genericName":"TLR4 Agonist GLA-SE","slug":"tlr4-agonist-gla-se","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Wistar Rabies Virus Strain PM-1503-3M Vaccine","genericName":"Wistar Rabies Virus Strain PM-1503-3M Vaccine","slug":"wistar-rabies-virus-strain-pm-1503-3m-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Atripla or Stribild","genericName":"Atripla or Stribild","slug":"atripla-or-stribild","phase":"marketed","mechanism":"Atripla and Stribild are fixed-dose combination antiretroviral drugs that inhibit HIV replication through multiple mechanisms targeting reverse transcriptase and integrase.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced patients (Atripla)","HIV-1 infection in treatment-naïve patients (Stribild)"],"catalyst":""},{"name":"Beta Carotene and Retinol","genericName":"Beta Carotene and Retinol","slug":"beta-carotene-and-retinol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Garlic oil","genericName":"Garlic oil","slug":"garlic-oil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"JAK Inhibitor","genericName":"JAK Inhibitor","slug":"jak-inhibitor","phase":"marketed","mechanism":"JAK inhibitors block Janus kinase enzymes, which are intracellular signaling proteins that transmit inflammatory and immune signals from cell surface receptors.","indications":["Myeloproliferative neoplasms (e.g., polycythemia vera, essential thrombocythemia, primary myelofibrosis)","Hematologic malignancies and related conditions"],"catalyst":""},{"name":"Liposome-encapsulated Daunorubicin-Cytarabine","genericName":"Liposome-encapsulated Daunorubicin-Cytarabine","slug":"liposome-encapsulated-daunorubicin-cytarabine","phase":"phase_3","mechanism":"A liposome-encapsulated combination of two chemotherapy drugs (daunorubicin and cytarabine) that delivers cytotoxic agents directly into leukemic cells to inhibit DNA synthesis and induce cell death.","indications":["Acute myeloid leukemia (AML) in elderly or unfit patients","Relapsed or refractory acute leukemia"],"catalyst":""},{"name":"Nicotine Gum","genericName":"Nicotine Gum","slug":"nicotine-gum","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nozin","genericName":"Nozin","slug":"nozin","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"T-cell Receptor-engineered T-cells","genericName":"T-cell Receptor-engineered T-cells","slug":"t-cell-receptor-engineered-t-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"chemoprotection","genericName":"chemoprotection","slug":"chemoprotection","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"endocrine-modulating drug therapy","genericName":"endocrine-modulating drug therapy","slug":"endocrine-modulating-drug-therapy","phase":"phase_3","mechanism":"Endocrine-modulating drug therapy works by modulating the body's endocrine system to treat various conditions.","indications":["Hormone receptor-positive breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPVEQ4SDc3S0ZKcEQ2bndaNDdVVjJUVjJSeFgzdTRkdFplYlFBWEVSUlNKOWtMV2p6dVhRdGN1UjhqanNZcThnWElmWTl6bF9SMTV2OVloYTAxaTdqdTB1RjMtbFc5Y1U0SXpWRldqRHY5d3lnV0pZQksyRlM1dVhDRmVFVnRFZUpYby0tWHNiTG9wMTMwTzNwQ2xMakp3WG5XTW44LUhRRDROckdEdzMzYkJISlE5dDhkSm1CQVc5MUdhbXZHX2hvMW1n?oc=5","date":"2026-04-01","type":"pipeline","source":"Pharmacy Practice News","summary":"Oral Chemotherapy Benefits With Pharmacist Managed Care - Pharmacy Practice News","headline":"Oral Chemotherapy Benefits With Pharmacist Managed Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQc3k0czdzZ01DdlUtcDhveVkydHM3dWlJVUdPemtseWVFTDRVa252NThUU1NiQk5IbUJZZndnQlRxTEpOZXVWUDFXNUtsNUtTa0lxOW5PcEhGTVhBOEkxX2gzQUs1WDdDSmoycU9zeTdjc2J6OWctZGoySGNWeHA4OVFnMTRvYzlwZXdNN0pUNEVGZXJX?oc=5","date":"2026-02-24","type":"pipeline","source":"Fred Hutchinson Cancer Center","summary":"Oncology Pharmacist - Fred Hutchinson Cancer Center","headline":"Oncology Pharmacist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNMXFVaWZhNFFDZFd1WFM5UEhHS2VGWUItTnI5ZUg2TDBxUkE4RFlzM1VfeVZuVXR1NjF6YjlSLTF3SU01TlVPNy1VMXZsREhPcGlXcG1RZ3BBVTIyMjNncmRTa1lVU1pDQ0ZIdEFwQW43a0xSTkdKd0MxZEp1SXZqTkloOWQ5Ri1lT0NCNUo2NXozT2xHcWVfb0twNTVGZw?oc=5","date":"2026-02-24","type":"pipeline","source":"Fred Hutchinson Cancer Center","summary":"Oncology Pharmacy Resident - Fred Hutchinson Cancer Center","headline":"Oncology Pharmacy Resident","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQb0F4ZGRSaDhtMlYwQWU3VDhJT1Z1OGpUempEcGJoSWNyb2JVZnhaWENORDAwV0hrQURIc2taQV85UXp6d2lxeEs4cFcyQWpwV25SMkZQM0RERmNzZHY1Y2lNMXJ4ZXlCTThLd0xlUHFJcEY1S1Z4OURmY09SR2txOXBsOXdpQzZ6VW43Vzc1ZEdDRThnZHBET1VhS1hEQdIBngFBVV95cUxQb0F4ZGRSaDhtMlYwQWU3VDhJT1Z1OGpUempEcGJoSWNyb2JVZnhaWENORDAwV0hrQURIc2taQV85UXp6d2lxeEs4cFcyQWpwV25SMkZQM0RERmNzZHY1Y2lNMXJ4ZXlCTThLd0xlUHFJcEY1S1Z4OURmY09SR2txOXBsOXdpQzZ6VW43Vzc1ZEdDRThnZHBET1VhS1hEQQ?oc=5","date":"2025-06-16","type":"pipeline","source":"Newswise","summary":"Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees | Newswise - Newswise","headline":"Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees | Newswise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5OOU1PeTE0RzdmMGh1SUZCS1ZYYWh1UUdvTXlCa2FEeTZmSUhBT0hzTS1oZ3hrT0VNYTlHNjNMWmdpY055MkNKNmpQTmI5MVRwLVppZzF4QndXQ2FwdDcyWGNENkVWZkFKdDJDTEZOVDIzWnh2dFRwcjc0WQ?oc=5","date":"2025-04-20","type":"pipeline","source":"Oncodaily","summary":"Cancer Center Near Me: Fred Hutchinson Cancer Center - Oncodaily","headline":"Cancer Center Near Me: Fred Hutchinson Cancer Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxObU9iSzFlZDJvU1VUZHhEMUV3SVpTLThWTDZqNFp2c2JEcEhBYUVFc1B6QWZkaWxGeWtBeFItZUhYT1UtQWNvVzNZN1ljR1QwRWFqNW9rUUxmTlJTdUlEYjQyTVdLVmF3M2JKcWZWYTE0c1BNWExmWTRvd1hTc2JBYy1wWVJYMWxOaTNIc1ZlSEpIeXM?oc=5","date":"2025-02-19","type":"pipeline","source":"The American Journal of Managed Care® (AJMC®)","summary":"Communication Is Key in Era of Oncologist Shortages, Experts Say - The American Journal of Managed Care® (AJMC®)","headline":"Communication Is Key in Era of Oncologist Shortages, Experts Say - The American Journal of Managed Care® (AJMC®)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNbU0ybVNRU1owanR4THBhdjJOVzBYRTc5WGZhM3dIZEE5LUdRVV9XZzlJTE9QWXUtWWV6Tl9qMVV6YWRudjhWb1FPc3dMbEFFRXgzbDZSaWJqbkFSTGxqUXhkSHB0NHJucTdtbXJERU5GM1dpNEFmWmtuM1VaMjdIWWNKU3VDRHk5bkNTOFRkSQ?oc=5","date":"2025-01-09","type":"pipeline","source":"Fred Hutchinson Cancer Center","summary":"50 years of doing hard things - Fred Hutchinson Cancer Center","headline":"50 years of doing hard things","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNamFCenhnNVZSejBqaFVld2I1UUxZbWtNakpucU5wWDY0NzRXbEExWGxCLTk2WjFxcnBNbGd1U2pScHNLZnA3Ukh3MUl6RjY4b3dLTWt2VWtuaVI2YlRCU0puNG1va21zVnhXNHVjek1QZUVWZGVNd1kwQ09YQS1vYS02cEh6MFB0TTB5ejZPTVNkdGFSVXFiZTZhTXVmZTl4RmlvMDQxRGZQd2RZWmp6eTlnU0NCQWNJZ3E1Ng?oc=5","date":"2024-09-27","type":"trial","source":"Fred Hutchinson Cancer Center","summary":"Clinical cancer research in the U.S. is increasingly dominated by pharmaceutical industry sponsors, study finds - Fred Hutchinson Cancer Center","headline":"Clinical cancer research in the U.S. is increasingly dominated by pharmaceutical industry sponsors, study finds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQN3VNbFBtMEh0UnI3LUl5Q3FSekdobENuRXF6ZWVtdmtreV9nQ25UUXdJMWxJZER1dU13WWhybUVzQjdGT2V1WjZZMDlUOE5PZ01yVS1lbUtMMXFYYVVZUkI5aW5CWXBJc2hhZUlwaG1HVHVDckphRnFPc0QyOXppZjBWZndtQTVnd0gtNzh0djBpbk1IOGRNYUR3?oc=5","date":"2022-10-03","type":"pipeline","source":"Fred Hutchinson Cancer Center","summary":"Fred Hutch begins rollout of new brand - Fred Hutchinson Cancer Center","headline":"Fred Hutch begins rollout of new brand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNZVVjSENoYkt2QWhHRWZWS1RBNUFUbFRNMVRZbmVreU5JaS0yUzlfcWM5bDBuNDVPLTZLMi1TbmhBMWhuMzBKT3dfT1V5bVlQN0tWdWZ0TGVCZzRzVl9YZjBNOUZnMm9FWjRWOGV5ZmxXS21OX0FjWGtXWUJBcFhQb0l6MXRvRVZxWFR2UE1SZUUtME1CSXNndFJobjRra3VBYWU0WUxQVmVIOTZ4RDVQM21lbDRlNDZtdVR4Xw?oc=5","date":"2022-09-08","type":"pipeline","source":"Fred Hutchinson Cancer Center","summary":"Fred Hutchinson Cancer Center receives $78 million gift to support precision oncology - Fred Hutchinson Cancer Center","headline":"Fred Hutchinson Cancer Center receives $78 million gift to support precision oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQTGFIbENNLXdNUjZWMzFrYmN4Z2NfNHdsRUtGVlAtTlJzNnNka3o0dlVQNy1sMHdpd0lydlVYaTdzSGh1Q0d5RkpDcy12VW8zSWtTclBteTRaSnVmWHRiTTh1RW1sajBJSWZKQ2hIM192Z1lYa21pMTdVOWFUbnA3WWdiYzZpaXEtRl9oX3Z2QQ?oc=5","date":"2022-04-01","type":"pipeline","source":"Fred Hutchinson Cancer Center","summary":"Fred Hutch and Seattle Cancer Care Alliance unite, reshape relationship with UW Medicine - Fred Hutchinson Cancer Center","headline":"Fred Hutch and Seattle Cancer Care Alliance unite, reshape relationship with UW Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQVTh5a2E4VjllRHJ6eGljbE13akFMd3l2Qm54ZXo2NWNRSVlEWTZzcG82OHBSZEVheGVhbXNsendtRlBOSmRRMlZ0WEtZeTJVZm14aGc5X0dQRlVwZFY1ZXdPQlE5UHd5b3lyRlFGTExFOUhKdDV0TElINUdMVTBjVDdZLWN6dUFQRGRGUWFTTF9TZ2ZFa3Q5VTZGTlhLamhJamZtSXZTT0FnREduSUF2cW94NUNjc2Q0UGFQWQ?oc=5","date":"2020-05-19","type":"deal","source":"Fred Hutchinson Cancer Center","summary":"Fred Hutch announces new collaboration with Roche leveraging digital technology to help cancer patients undergoing chemotherapy - Fred Hutchinson Cancer Center","headline":"Fred Hutch announces new collaboration with Roche leveraging digital technology to help cancer patients undergoing chemo","sentiment":"neutral"}],"patents":[],"drugCount":14,"phaseCounts":{"marketed":7,"phase_1":3,"phase_3":2,"discontinued":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}